Načítá se...

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma

Background: RUFY3 (RUN and FYVE domain-containing protein 3) has been shown to participate in cell migration, membrane transportation, and cellular signaling and is dysregulated in several cancer processes. However, the role of RUFY3 in lung cancer remains unclear. In the present study, we aimed to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cancer
Hlavní autoři: Men, Wanfu, Li, Wenya, Li, Yu, Zhao, Jungang, Qu, Xiaohan, Li, Peiwen, Gong, Shulei
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6856751/
https://ncbi.nlm.nih.gov/pubmed/31772661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.35072
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!